Non-Opioid Pain Patch Market Report: Trends, Forecast and Competitive Analysis to 2030

Non-Opioid Pain Patch Market Report: Trends, Forecast and Competitive Analysis to 2030

Non-Opioid Pain Patch Trends and Forecast

The future of the global non-opioid pain patch market looks promising with opportunities in the hospital, online pharmacy, and drug store markets. The global non-opioid pain patch market is expected to grow with a CAGR of 4.2% from 2024 to 2030. The major drivers for this market are increase in chronic and acute pain related disorders and rising preference for non-invasive pain management.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Non-Opioid Pain Patch by Segment

The study includes a forecast for the global non-opioid pain patch by patch type, distribution channel, and region.

Non-Opioid Pain Patch Market by Patch Type [Shipment Analysis by Value from 2018 to 2030]:

• Lidocaine Patches
• Diclofenac Patches
• Methyl Salicylate Patches
• Capsaicin Patches
• Ketoprofen Patches

Non-Opioid Pain Patch Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Online Pharmacies
• Drug Stores

Non-Opioid Pain Patch Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Non-Opioid Pain Patch Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies non-opioid pain patch companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the non-opioid pain patch companies profiled in this report include-

• Acorda Therapeutics
• Teva Pharmaceutical Industries
• GlaxoSmithKline
• Endo Pharmaceuticals
• Hisamitsu Pharmaceutical
• IBSA Institut Biochimque
• Alkermes

Non-Opioid Pain Patch Market Insights

Lucintel forecasts that lidocaine is expected to witness the highest growth over the forecast period.

Within this market, hospital is expected to witness the highest growth over the forecast period.

North America is expected to witness the highest growth over the forecast period.

Features of the Global Non-Opioid Pain Patch Market

Market Size Estimates: Non-opioid pain patch market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Non-opioid pain patch market size by patch type, distribution channel, and region in terms of value ($B).

Regional Analysis: Non-opioid pain patch market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different patch types, distribution channels, and regions for the non-opioid pain patch market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the non-opioid pain patch market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for non-opioid pain patch market?

Answer: The global non-opioid pain patch market is expected to grow with a CAGR of 4.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the non-opioid pain patch market?

Answer: The major drivers for this market are increase in chronic and acute pain related disorders and rising preference for non-invasive pain management.

Q3. What are the major segments for non-opioid pain patch market?

Answer: The future of the non-opioid pain patch market looks promising with opportunities in the hospital, online pharmacy, and drug store markets.

Q4. Who are the key non-opioid pain patch market companies?

Answer: Some of the key non-opioid pain patch companies are as follows:

• Acorda Therapeutics
• Teva Pharmaceutical Industries
• GlaxoSmithKline
• Endo Pharmaceuticals
• Hisamitsu Pharmaceutical
• IBSA Institut Biochimque
• Alkermes

Q5. Which non-opioid pain patch market segment will be the largest in future?

Answer: Lucintel forecasts that lidocaine is expected to witness the highest growth over the forecast period.

Q6. In non-opioid pain patch market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the non-opioid pain patch market by patch type (lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, and ketoprofen patches), distribution channel (hospitals, online pharmacies, and drug stores), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.